HealthVerity IPGE Blog Series: Privacy
In the first installment of our HealthVerity IPGE blog series covering the four foundational...
When billed and allowed amounts aren’t enough: HealthVerity market cost offering in taXonomy
A better way to measure healthcare costs in closed claims data This is the second post in our four-part taXonomy X blog series (part 1 here), and here we’ll discuss one of the most common pain points in closed claims analytics: costs. Specifically,...
COVID-19 RWD Waterfall Strategy
How real-world data (RWD) from open and closed claims and beyond can be layered to better explore...
HealthVerity IPGE Blog Series: Identity
Patient Identity Resolution: The next era of healthcare data interoperability The HealthVerity...
Is Pharma Right About the Need for a COVID-19 Booster Shot?
The intrinsic role of real-world data to help determine the necessity for booster shots as new...
HealthVerity IPGE and the challenges with real-world data
In a recent HealthVerity LIVE webinar, we took an in-depth look at how the HealthVerity IPGE...
Can real-world data enrich clinical trials?
COVID-19 urgently highlighted the need for real-time data, and with it, the need to tap into a...
The key to longitudinal patient journeys
A data-rich longitudinal patient journey is key to research and development, commercialization and...
The modern way to data: An executive conversation with AWS
This post was originally published on the AWS for Industries blog by Jared Saul, Global Head of ...
How RWE can support drug development during COVID-19 and beyond
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
How Longitudinal Patient Insights Transform Clinical Trials
COVID-19 has heightened the need for an expanded understanding of clinical trial populations and...